 |
Expert Meeting on Evidence-Based Review of Genomic Applications
|
Monday, January 24 |
Time |
Activity |
Moderator |
| 7:30 - 8:00 |
Continental Breakfast |
|
| 8:00 - 8:15 |
Welcome and Introductions |
Diane Wagener |
| 8:15 – 8:30 |
Public Health Assessment of Genomic Applications |
Muin Khoury
( View Presentation ) |
| 8:30– 8:45 |
Meeting Goals and Objectives |
Diane Wagener |
| 8:45 – 9:00 |
Comments on current approaches to evaluation and future potential - Tab 3 |
Linda Bradley |
| 9:00 - 9:30 |
Components of Evaluation : Describing the Disorder, Test, and Setting - Tab 4 |
James Haddow |
| 9:30 - 10:30 |
Components of Evaluation : Analytic Validity (AV) - Tab 5 |
Glenn Palomaki |
| 10:30–10:45 |
Break |
|
| 10:45 - 12:15 |
Components of Evaluation : Clinical Validity (CV)- Tab 6 |
Ingeborg Blancquaert |
12:15 - 12:30 |
Break and Buffet - Return for Working Lunch |
|
| 12:30 - 2:00 |
Components of Evaluation : Clinical Utility - Tab 7 |
Steve Teutsch |
| 2:00 - 3:00 |
Components of Evaluation : Ethical, Legal and Social Implications - Tab 8 |
Wylie Burke |
| 3:15 - 3:30 |
Break |
|
| 3:30 - 4:00 |
Review and Updating of Reports - Tab 9 |
Peter Briss |
| 4:00 - 5:00 |
Day 1 Facilitated Discussion (All attendees)
- Development of themes/conclusions from the sessions
- Questions and comments
|
Diane Wagener |
|
Tuesday, January 25 |
Time |
Activity |
Moderator |
| 8:00 - 8:30 |
Continental Breakfast |
|
| 8:30 - 10:00 |
Products and Dissemination of Information - Tab 10 |
Gurvaneet Randhava |
| 10:00 - 10:15 |
Break |
|
| 10:15 - 12:15 |
Facilitated Discussion (All attendees)
- Review of themes and conclusions
- Areas of agreement
- Compatibility with current standards of practice?
- How can we facilitate/support the development of research agendas based on identified gaps in evidence?
- Is there any consensus on 5-10 topics that would be high priority for review?
|
Al Berg |
| 12:15 - 12:30 |
Summary of Meeting/Closing Remarks
- Elicit suggestions for other professionals to involve as advisors, content experts, or peer-reviewers
- Request for information about relevant studies currently being conducted (PI, contact information, and project description)
- Closing thoughts and solicitation of opinion from participants on the desired outcome from this meeting
- Expression of thanks from RTI and CDC for helpful insights and participation
|
Diane Wagener
Muin Khoury
Linda Bradley |
|
|
